A. Mitchell

Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma

S. Bray, G. Inman, P. Coates, 2018, Oncotarget.

Reduced SMAD 2 / 3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma

S. Bray, G. Inman, P. Coates, 2018 .

Tributyrin, a Butyrate Pro-Drug, Primes Satellite Cells for Differentiation by Altering the Epigenetic Landscape

Jiuzhou Z. Song, C. Stahl, Jianan Liu, 2021, Cells.